We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Limited Access to Ultrasound Impedes Efforts to Help Prevent Pediatric Stroke

By HospiMedica International staff writers
Posted on 05 May 2009
The number of children with a specific blood disorder undergoing an ultrasound to help prevent stroke has increased significantly in the past 10 years since a major study demonstrated its benefits. More...
However, limited access to labs that perform this type of screening appears to be an obstacle to helping these children who are at a high risk of stroke.

In the study, published in the April 14, 2009, issue of the journal Neurology, the researchers tracked 157 children with sickle cell disease in northern California (USA) for an average of 8.5 years. Sickle cell disease is a lifelong blood disorder that increases a child's risk of stroke. Approximately 1 child out of 10 with the disease suffers a stroke by age 20.

For the study, researchers determined how many children underwent a transcranial Doppler ultrasound (TCD) screening since 1998, when a key study, known as the STOP (Stroke Prevention Trial in Sickle Cell Anemia) trial, was published. The STOP trial revealed a more than 90% reduction in the stroke rate of children with sickle cell disease who received a TCD screening and were identified as having a high risk of stroke and could therefore have blood transfusion therapy.

Since the STOP trial, the current study found the rate of TCD screening among children with sickle cell disease has increased six-fold while the yearly stroke rate has decreased by more than half. However, researchers found children living farther away from a vascular laboratory were less likely to be screened. "Stroke in children with sickle cell disease should be a largely preventable disease, however, not all children at risk are getting screened," said Heather J. Fullerton, M.D., MAS, from the University of California, San Francisco (UCSF; USA). "Limited access to labs that perform TCD screening, even among kids with comprehensive health insurance, appears to be a barrier to helping these kids reduce their high risk of stroke. Increased availability of these screening labs may help prevent stroke in these high risk children."

Guidelines from the American Academy of Neurology (St. Paul, MN, USA) recommend TCD screening of children with sickle cell disease beginning at age two.

Related Links:

University of California, San Francisco




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.